Chronic myeloid leukaemia as a model of disease evolution in human cancer (Q34631354)

3 August 2017

1 reference

title

Chronic myeloid leukaemia as a model of disease evolution in human cancer (English)

1 reference

3 August 2017

1 reference

Junia V Melo

1 reference

3 August 2017

David J Barnes

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

3 August 2017

published in

Nature Reviews Cancer

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

441-453

1 reference

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

3 August 2017

cites work

1 reference

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

31 March 2020

1 reference

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

31 March 2020

1 reference

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

31 March 2020

1 reference

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

31 March 2020

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

31 March 2020

1 reference

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

31 March 2020

1 reference

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

31 March 2020

1 reference

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

31 March 2020

1 reference

Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation

31 March 2020

1 reference

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

31 March 2020

1 reference

The biology of CML blast crisis

31 March 2020

1 reference

IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line

31 March 2020

1 reference

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

31 March 2020

1 reference

Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells

31 March 2020

1 reference

STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells

31 March 2020

1 reference

BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner

31 March 2020

1 reference

Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7.

31 March 2020

1 reference

Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia

31 March 2020

1 reference

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia

31 March 2020

1 reference

The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage

31 March 2020

1 reference

Stem cell origin of cancer and differentiation therapy

31 March 2020

1 reference

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

31 March 2020

1 reference

Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.

31 March 2020

1 reference

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

31 March 2020

1 reference

Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.

31 March 2020

1 reference

Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.

31 March 2020

1 reference

Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells

31 March 2020

1 reference

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

31 March 2020

1 reference

Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia

31 March 2020

1 reference

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9

31 March 2020

1 reference

Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia

31 March 2020

1 reference

NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia

31 March 2020

1 reference

Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15).

31 March 2020

1 reference

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

31 March 2020

1 reference

A role for Wnt signalling in self-renewal of haematopoietic stem cells

31 March 2020

1 reference

Wnt proteins are lipid-modified and can act as stem cell growth factors

31 March 2020

1 reference

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation

31 March 2020

1 reference

Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia

31 March 2020

1 reference

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

31 March 2020

1 reference

Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta

31 March 2020

1 reference

Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression

31 March 2020

1 reference

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

31 March 2020

1 reference

Investigation on the role of the ATM gene in chronic myeloid leukaemia

31 March 2020

1 reference

BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint

31 March 2020

1 reference

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

31 March 2020

1 reference

Chk1 and Chk2 kinases in checkpoint control and cancer

31 March 2020

1 reference

An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication

31 March 2020

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

31 March 2020

1 reference

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

31 March 2020

1 reference

Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells

31 March 2020

1 reference

BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

31 March 2020

1 reference

ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks.

31 March 2020

1 reference

DNA double-strand breaks: signaling, repair and the cancer connection

31 March 2020

1 reference

BCR-ABL down-regulates the DNA repair protein DNA-PKcs

31 March 2020

1 reference

DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining

31 March 2020

1 reference

BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance

31 March 2020

1 reference

BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks

31 March 2020

1 reference

BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells

31 March 2020

1 reference

BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance

31 March 2020

1 reference

A recurrent mutation in PALB2 in Finnish cancer families.

31 March 2020

1 reference

Molecular mechanism of nucleotide excision repair.

31 March 2020

1 reference

p210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation

31 March 2020

1 reference

The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein

31 March 2020

1 reference

Mammalian DNA nucleotide excision repair reconstituted with purified protein components.

31 March 2020

1 reference

Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition

31 March 2020

1 reference

Multiple mutations and cancer

31 March 2020

1 reference

Increase in mutant frequencies in mice expressing the BCR-ABL activated tyrosine kinase

31 March 2020

1 reference

Mutator phenotype of BCR--ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase beta

31 March 2020

1 reference

Genome maintenance mechanisms for preventing cancer

31 March 2020

1 reference

Telomere reduction in human colorectal carcinoma and with ageing

31 March 2020

1 reference

A critical role for telomeres in suppressing and facilitating carcinogenesis

31 March 2020

1 reference

Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia

31 March 2020

1 reference

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

31 March 2020

1 reference

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

31 March 2020

1 reference

Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase

31 March 2020

1 reference

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

31 March 2020

1 reference

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

31 March 2020

1 reference

Managing the patient with chronic myeloid leukemia through and after allogeneic stem cell transplantation

31 March 2020

1 reference

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

31 March 2020

1 reference

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

31 March 2020

1 reference

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

31 March 2020

1 reference

Gene expression changes associated with progression and response in chronic myeloid leukemia

31 March 2020

1 reference

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

31 March 2020

1 reference

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

31 March 2020

1 reference

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

31 March 2020

1 reference

Chronic myelogenous leukemia molecular signature.

31 March 2020

1 reference

A gene-expression signature as a predictor of survival in breast cancer

31 March 2020

1 reference

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

31 March 2020

1 reference

Diagnostics. Amid debate, gene-based cancer test approved

31 March 2020

1 reference

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.

31 March 2020

1 reference

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML.

31 March 2020

1 reference

Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia

31 March 2020

1 reference

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

31 March 2020

1 reference

Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase

31 March 2020

1 reference

Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas

31 March 2020

1 reference

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

31 March 2020

1 reference

The life and death of DNA-PK.

31 March 2020

1 reference

Considering the cancer consequences of altered DNA polymerase function

31 March 2020

1 reference

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia

31 March 2020

1 reference

p53 in chronic myelogenous leukemia in acute phase

31 March 2020

1 reference

BCR/ABL activates mdm2 mRNA translation via the La antigen

31 March 2020

1 reference

Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia

31 March 2020

1 reference

Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia.

31 March 2020

1 reference

Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis

31 March 2020

1 reference

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

31 March 2020

1 reference

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

31 March 2020

1 reference

Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.

31 March 2020

1 reference

The INK4A/ARF locus and its two gene products

31 March 2020

1 reference

The regulation of INK4/ARF in cancer and aging

31 March 2020

1 reference

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

31 March 2020

1 reference

Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase

31 March 2020

1 reference

Chronic myeloid leukemia blast crisis arises from progenitors.

31 March 2020

1 reference

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

31 March 2020

1 reference

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

31 March 2020

1 reference

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

31 March 2020

1 reference

Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib

31 March 2020

1 reference

Dynamics of chronic myeloid leukaemia.

31 March 2020

1 reference

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

31 March 2020

1 reference

Dysregulated expression of the major telomerase components in leukaemic stem cells.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC2147

1 reference

Dimensions Publication ID

3 August 2017

1029023662

0 references

1 reference